News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Survodutide safe to use in cirrhosis patients
27 Oct 2024
Treatment with survodutide, which has previously shown its efficacy in reducing body weight and glycaemia in people with obesity or type 2 diabetes, is well tolerated by patients with compensated or decompensated cirrhosis, reports a study.
27 Oct 2024








